Article
Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells
26 Sept 2018
Abstract excerpt
Cancers are complex diseases having several unique features, commonly described as ‘hallmarks of cancer’. Among them, altered signaling pathways are the common characteristic features that drive cancer progression; this is achieved due to mutations that lead to the activation of growth promoting(s) oncogenes and inactivation of tumor suppressors. As a result of which, cancer cells increase their glycolytic rate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
